Ernő Duda is founder and President of the Hungarian Biotechnology Association, a representative organization active in lobbying for the interests of its member companies and the biotechnology sector in Hungary. As a serial entrepreneur and investor, he has founded or co-founded over 20 companies operating in various industries, ranging from biotechnology, high-tech, and IT firms to e-commerce and business consultancy ventures. He has co-founded and is the Chairman of Aquincum Technology Incubator. He has also co-founded and is the Business Development Director of Creative Accelerator. By participating in the work of these incubators, he selects and mentors start-ups that has the potential to develop into successful companies, be competitive enough to enter international markets, grow quickly, and become targets of future venture capital investments.
As an Assistant Professor, his course 'Biotechnology from a Business Perspective' has been running at the University of Szeged since 2004, and Mr. Duda also teaches entrepreneurship and biotechnology at various universities in both Hungarian and English. Mr. Duda was a member of the Research and Technology Innovation Council of the National Office for Research and Technology for 6 years, a member of the Board of Trustees of the Bay Zoltán Foundation for Applied Research for 8 years, and a member of EuropaBio for 2 years. He currently sits on the Board of the Hungarian Association for Innovation. He has been awarded the Order of Merit of the Republic of Hungary for his distinguished contribution to the development of the Hungarian biotechnology industry, and was granted the Dennis Gabor Award in 2012.
Dr. Gerencsér joined Solvo in June 2020 as Director of Operations. Prior to that he worked as managing director at BioBlocks Kft, Budapest, Hungary. Previously, he spent four years at ComInnex, Inc, Budapest, Hungary, first as Director of Chemistry and later as Chief Operating Officer. Between 2006 and 2012 Dr. Gerencsér worked at AMRI Hungary as Assistant Director of Chemistry and Innovation leading a department of over 40 scientists. He was responsible for the successful management of contract research projects at highest customer satisfaction. Dr. Gerencsér started his industrial career at ComGenex in 1999 where he held positions of increasing responsibility and was appointed to group leader in 2003. He supervised successful multiyear contract research collaborations with leading agro and pharma companies. Dr. Gerencsér received a master’s degree in Medicinal Chemistry and his Ph.D. in Chemistry from the University of Technology and Economics of Budapest. He is a co-author of over 10 peer-reviewed publications, co-inventor in several patents and holds an honorary associate professor title at the Budapest University of Technology and Economics. Beside his scientific and management activities he also actively participated in the development and introduction of ComGenex’s proprietary LIMS including an ELN module in the early 2000’s.
Dr. Kis received a Master’s Degree in Biotechnology from University of Technology and Economics of Budapest, and her Ph.D. in Biochemistry from University of Szeged. She began her career at SOLVO in 2003 as a scientist in the Research and Development Laboratory. Her focus was on development of various membrane transporter assays and she was involved in a number of scientific grants and international collaborations. From 2014 she became the Head of Production Laboratory, with overall responsibility for cell membrane preparations and assay development. She was subsequently promoted to oversee operational management of the R&D department in 2016. Since 2018 she has held the position of Scientific Director, responsible for the operation of all laboratories at senior management level. Dr. Kis has contributed to 22 peer reviewed scientific papers.
Kitti Zsák Péterné Szabó graduated as a Biochemical Engineer (MSc) and completed Quality Assurance Special Studies at the Budapest University of Technology and Economics. She started her career at SOLVO Biotechnology in 2008 as a scientist in the Research and Development Laboratory where she worked on the species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2). She is a certified ISO 9001 Internal Auditor and Quality Assurance Manager and she is qualified in ISO/IEC 17025 Document Management and GLP. She has joined the Quality Assurance Unit in 2013 and she became the Head of the Quality Assurance Unit in 2014. Since 2017 she has been the Director of Operational Support, therefore responsible for the operations of the export, import, procurement, quality assurance and quality control processes.
Following B.Sc. and M.Res. degrees, Joe Zolnerciks was awarded his Ph.D. in membrane protein biochemistry from Imperial College London. He held positions studying drug transporters and drug-drug interactions at the University of Washington, University of London, and University of Basel, before joining SOLVO Biotechnology in 2012 as Head of Production. In this role, he was responsible for overseeing product development and manufacture, as well as leading improvements in bioprocess development. As a result of subsequent robust growth, he joined SOLVO’s North American subsidiary in 2014 as Director of ADME-Tox Services, opening SOLVO’s West Coast US office in Seattle. In 2016, Dr Zolnerciks was promoted to his current position as Vice-President of Business Development where he oversees SOLVO’s global sales, business development, and marketing activities. He is the author of over 30 research papers, reviews, book chapters, and presentations in the field of drug transporters and drug-induced toxicity.
Krisztina Kecskés is graduated at the Szeged University, Faculty of Arts (Humanities and Social Science). She is a certified coach in Business and Management Coaching, also has certification as a Trainer (specialized in leadership topics & organizational design). She has more than 15 years of experience in international management. She started her professional career at MOM Zrt (DIEHL Group) in 2007 as HR Manager, later took responsibility in automotive and industrial engineering sectors as HR Director in Hungary and Austria. Before joining to Solvo she was responsible for both HR and Communications in pharma industry. Since 2020 she has been the Director of HR at Solvo Biotechnology, and also responsible for the Veszprém site of the American owner, Charles River Laboratories.
Dr. Németh has 15 years of experience in the biotechnology and drug development industry, before joining Solvo Biotechnology in 2020, he was most recently a Director of Research and Development at Intrexon Corporation focusing on the commercialization of pharma and biotech projects. Priori he led the Molecular and Cellular Engineering Unit at Codexis Lab Hungary. He is an experienced molecular biologist, high throughput assay scientist, and protein engineer and has demonstrated expertise in synthetic biology and laboratory automation. He started his scientific training as a Pharmaceutical Chemist and moved to study protein chemistry at the Institute of Enzymology, Hungary, and spent several years at Tokyo University of Pharmacy and Life Science. Before leaving academia in 2007, he was a postdoctoral researcher at the Department of Biochemistry, Eotvos Lorand University, Hungary. Dr. Németh co-authored two international patents and several peer-reviewed papers in international journals and received his Ph.D. from Eotvos Lorand University in 2003.
Zsuzsanna Gáborik received a Master’s Degree in Bioengineering from University of Technology and Economics, Budapest. She earned her Ph.D. in Cellular and Molecular Physiology at the Semmelweis University, Budapest, and started her academic carrier at Department of Physiology at the Semmelweis University. She joined SOLVO in 2011 and started working in the Business Development team, with responsibility for service and product launches and scientific sales support, and participated as an editor on SOLVO’s Transporter Book. After four years her focus changed, and she joined the Research and Development Department as a Scientific Development Manager responsible for assay development. In 2016 she took over the operational management of the R&D Laboratory, and she is currently Head of the R&D Laboratory. She has contributed to 17 peer reviewed scientific publications.
Zoltán Timár graduated in organic chemistry at University of Szeged in 2000, has a record of academic research at Bristol University, École Nationale Superieure de Chimie de Paris and University of Colorado at Boulder. Dr Timár has authored publications and patents, applying novel synthetic organic and analytical chemistry techniques at the Nucleic Acid Solutions Division of Agilent Technologies in Boulder, Colorado as an expert scientist. His main interest is in commercializing scientific research methods and products in the fields of pharmaceuticals and analytical sciences. His contribution to industrial research resulted in the worldwide commercialization of the TC-RNA chemistry to synthesize natural and modified RNA molecules over 100 nucleotides long. He developed analytical methodologies and software to sequence oligonucleotides. Dr. Timár is Head of the Bioanalytical Laboratory and Automation, leading a team of PhD scientists, overseeing bioanalytical and automated transporter and drug metabolism assays. Under his leadership, Solvo analytical and automation services strive to continuously develop by best laboratory practices and instrumentation and aiming to be outstanding quality, highly productive and dependable provider for Solvo customers all over the world.
Roelof de Wilde received his MSc degree in Molecular Biology and Biotechnology with an orientation on management from the University of Groningen, the Netherlands. He started his professional career as Study Director at SOLVO Biotechnology, Budapest, Hungary, where his main responsibilities were conducting contract-based research in the lab on drug-membrane transporter interactions. From 2012 to 2016 he served clients in North American territory as Study Manager, during which he was responsible for close to 200 contract research studies. During this period, he designed a series of data analysis and interpretation templates to streamline internal data processing in addition to helping implement new techniques to study transporter interactions in SOLVO’s labs (including hepatocyte uptake and B-clear® assays). In 2016 his responsibilities increased with a new role as Head of the North-American team, moving into a more business oriented position. Following this and after a short transition period as Head of the European team he was promoted to Director of Sales in the end of 2017, becoming responsible for both the European and Asian-Pacific business development. Backed up by his strong technical background and experience working with clients in the pharmaceutical industry globally, he is currently managing a team of several Study- and Account Managers.
Diána Szacsuri has more than 15 years’ experience in Financial accounting and Controlling. Graduated as Financial Economist at Szent István University at 2001, and MBA at Financials at 2015 at Eszterházy Károly University (collaboration with OUM). She is a certified Tax advisor and Chartered Accountant. Started her carrier as Financial manager at 2001 in the automotive and engineering industry at EXIR Hungary Zrt. After spending 12 years there from 2014-2019 worked as a Plant Controller at Modine Hungária Kft (MODINE Group). She joined SOLVO in July 2020.